Brief: Lisata Therapeutics Announces Encouraging Preliminary Results From The Pancreatic Cancer Cohort
29/09/2025 13:26
Sept 29 (Reuters) - Lisata Therapeutics Inc LSTA.O: LISATA THERAPEUTICS ANNOUNCES ENCOURAGING PRELIMINARY RESULTS FROM THE PANCREATIC CANCER COHORT OF THE CENDIFOX TRIAL Source text: ID:nGNX2S5nDM Further company coverage: LSTA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco